Definition of Drug-induced immune hemolytic anemia:

Drug-induced immune hemolytic anemia is a blood disorder that occurs when a medicine triggers the body's defense (immune) system to attack its own red blood cells. This causes red blood cells to break down earlier than normal, a process called hemolysis.

See also: Hemolytic anemia

Causes, incidence, and risk factors:

In some cases, a drug can cause the immune system to mistakenly think your own red blood cells are dangerous, foreign substances. Antibodies then develop against the red blood cells. The antibodies attach to red blood cells and cause them to break down too early.

Drugs that can cause this type of hemolytic anemia include:

• Cephalosporins (a class of antibiotics) -- most common cause
• Dapsone
• Levodopa
• Levofloxacin
• Methyldopa
• Nitrofurantoin
• Nonsteroidal anti-inflammatory drugs (NSAIDs)
• Penicillin and its derivatives
• Phenazopyridine (pyridium)
• Quinidine

There are other, rarer causes of drug-induced hemolytic anemia. This includes hemolytic anemia associated with glucose-6 phosphate dehydrogenase (G6PD) deficiency. In this case, the breakdown of red blood cells is due to a certain type of stress in the cell, rather than the body's immune system.

Drug-induced hemolytic anemia is rare in children.